Tenet Healthcare Corporation $THC Shares Sold by Sterling Capital Management LLC

Sterling Capital Management LLC decreased its holdings in Tenet Healthcare Corporation (NYSE:THC) by 34.8% in the 1st quarter, Holdings Channel reports. The institutional investor owned 6,008 shares of the company’s stock after selling 3,207 shares during the period. Sterling Capital Management LLC’s holdings in Tenet Healthcare were worth $1,134,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Price T Rowe Associates Inc. MD increased its position in Tenet Healthcare by 1.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,490,350 shares of the company’s stock worth $1,488,484,000 after purchasing an additional 119,809 shares during the last quarter. Boston Partners grew its stake in shares of Tenet Healthcare by 15.7% during the 4th quarter. Boston Partners now owns 3,642,136 shares of the company’s stock valued at $723,804,000 after buying an additional 494,581 shares during the period. AQR Capital Management LLC increased its holdings in shares of Tenet Healthcare by 20.3% during the 4th quarter. AQR Capital Management LLC now owns 2,256,539 shares of the company’s stock worth $448,419,000 after buying an additional 380,116 shares during the last quarter. Ameriprise Financial Inc. boosted its holdings in Tenet Healthcare by 8.0% in the second quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock valued at $373,020,000 after acquiring an additional 157,109 shares during the last quarter. Finally, Norges Bank acquired a new stake in Tenet Healthcare during the fourth quarter worth about $248,494,000. 95.44% of the stock is owned by institutional investors and hedge funds.

Tenet Healthcare Stock Down 0.1%

NYSE THC opened at $186.90 on Wednesday. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. Tenet Healthcare Corporation has a fifty-two week low of $146.60 and a fifty-two week high of $247.21. The business has a 50 day moving average price of $180.85 and a two-hundred day moving average price of $197.27. The stock has a market cap of $16.10 billion, a PE ratio of 9.72, a P/E/G ratio of 1.54 and a beta of 1.28.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. The company had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business’s quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the firm posted $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, sell-side analysts predict that Tenet Healthcare Corporation will post 17.61 EPS for the current fiscal year.

Insider Transactions at Tenet Healthcare

In other news, Director Nadja West sold 3,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the completion of the sale, the director owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. This trade represents a 10.79% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director J Robert Kerrey sold 5,638 shares of Tenet Healthcare stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total transaction of $983,943.76. Following the completion of the sale, the director owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.97% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on THC. Robert W. Baird decreased their target price on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a report on Tuesday, May 5th. TD Cowen reduced their price target on shares of Tenet Healthcare from $242.00 to $233.00 and set a “buy” rating on the stock in a research report on Monday, June 22nd. Barclays dropped their price objective on shares of Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating for the company in a research report on Tuesday, May 5th. Guggenheim cut their target price on shares of Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Finally, Royal Bank Of Canada decreased their price target on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a research report on Friday, May 1st. Eighteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, Tenet Healthcare has an average rating of “Moderate Buy” and a consensus price target of $244.32.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.